Accredo Health quarterly net falls, misses expectations

AudeLagorce

LONDON (MarketWatch) -- Specialty pharmaceuticals company Accredo Health, Inc.
acdo
said third-quarter net income fell to $20.2 million, or 40 cents a share, from $21.1 million, or 43 cents a share, in the year-earlier quarter, as gross profit margins fell to 16.3% from 20.5%. The results missed the average forecast for earnings of 43 cents a share of analysts polled by Thomson First Call. Revenue for the period climbed 26% to $517 million, partly thanks to new products.

Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.